In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Sanofi and Nichi-Iko form generics joint venture

Executive Summary

Sanofi-Aventis KK and Japanese drug manufacturer Nichi-Iko Pharmaceutical Co. Ltd. have decided to form a new joint venture, Sanofi-Aventis Nichi-Iko KK, to carry out generics marketing in Japan.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Joint Venture
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register